News Breaks |
|
|
| September 28, 2012 |
| 06:23 EDT |  | ASTX, JNJ | Astex says Janssen receives approval in EU for DACOGEN
Astex Pharmaceutical (ASTX) announced that Janssen-Cilag International NV (JNJ) was notified that the European Commission has approved the marketing authorization for DACOGEN for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia. In accordance with Astex's license agreement with Eisai, Astex may receive up to $17.5M in future payments if milestones are achieved for Dacogen globally. |
|
|
News For ASTX;JNJ From The Last 14 Days Check below for free stories on ASTX;JNJ the last two weeks. |
|
|
| May 21, 2013 |
| 07:24 EDT |  | JNJ | Global Health Care to host a conference
 Subscribe for More Information |
|
| May 17, 2013 |
| 06:19 EDT |  | JNJ | J&J to end sales of of metal-on-metal hip replacements, Bloomberg reports
Subscribe for More Information |
|
| May 15, 2013 |
| 16:51 EDT | | JNJ | FDA approves Simponi to treat ulcerative colitis
Subscribe for More Information |
|
| May 10, 2013 |
| 11:48 EDT | | JNJ | Drugmakers to face pressure on U.S. prices, Reuters says
Subscribe for More Information |
|
| 06:16 EDT | | JNJ | Obesity surgery booming in India, Bloomberg reports
Subscribe for More Information |
|
| May 9, 2013 |
| 17:09 EDT | | JNJ | Johnson & Johnson deal to settle sales practices probe stalls, WSJ reports
Johnson & Johnson's $2.2B settlement with the Justice Department related to its promotion of certain drugs is on hold as the company is looking to avoid language in the agreement that could make it vulnerable to private lawsuits, reports The Wall Street Journal, citing people familiar with the talks. Reference Link |
|
| 09:51 EDT | | JNJ | J&J unit says first patient enrolled in reMARQable study
Subscribe for More Information |
|
| May 8, 2013 |
| 07:38 EDT | | JNJ | BofA/Merrill's medical tech analyst hold an analyst/industry conference call
Subscribe for More Information |
|
| 06:11 EDT |  | ASTX | Astex Pharmaceuticals implied volatility at upper end of index mean range
Subscribe for More Information |
|
|
|
|
|
